Plasma NfL Has Diagnostic and Prognostic Performance for Alzheimer Disease in Adults With Down Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Diagnostic and Prognostic Performance and Longitudinal Changes in Plasma Neurofilament Light Chain Concentrations in Adults With Down Syndrome: A Cohort Study
Lancet Neurol 2021 Aug 01;20(8)605-614, M Carmona-Iragui, D Alcolea, I Barroeta, L Videla, L Muñoz, KL Van Pelt, FA Schmitt, DD Lightner, LM Koehl, G Jicha, S Sacco, C Mircher, SE Pape, R Hithersay, ICH Clare, AJ Holland, G Nübling, J Levin, SH Zaman, A Strydom, AS Rebillat, E Head, R Blesa, A Lleó, J ForteaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.